84 related articles for article (PubMed ID: 12183060)
1. Urokinase is required for the formation of mactinin, an alpha-actinin fragment that promotes monocyte/macrophage maturation.
Luikart S; Masri M; Wahl D; Hinkel T; Beck JM; Gyetko MR; Gupta P; Oegema T
Biochim Biophys Acta; 2002 Aug; 1591(1-3):99-107. PubMed ID: 12183060
[TBL] [Abstract][Full Text] [Related]
2. Mactinin treatment promotes wound-healing-associated inflammation in urokinase knockout mice.
Luikart SD; Levay-Young B; Hinkel T; Shearer J; Mills C; Caldwell MD; Gyetko MR; Oegema TR
Wound Repair Regen; 2006; 14(2):123-8. PubMed ID: 16630100
[TBL] [Abstract][Full Text] [Related]
3. Mactinin: a modulator of the monocyte response to inflammation.
Luikart SD; Krug HE; Nelson RD; Hinkel T; Majeski P; Gupta P; Mahowald ML; Oegema T
Arthritis Res Ther; 2003; 5(6):R310-6. PubMed ID: 12932295
[TBL] [Abstract][Full Text] [Related]
4. Mactinin, a fragment of cytoskeletal alpha-actinin, is a novel inducer of heat shock protein (Hsp)-90 mediated monocyte activation.
Luikart SD; Panoskaltsis-Mortari A; Hinkel T; Perri RT; Gupta K; Oegema TR; Gupta P
BMC Cell Biol; 2009 Aug; 10():60. PubMed ID: 19715605
[TBL] [Abstract][Full Text] [Related]
5. HL-60 cells degrade alpha-actinin to produce a fragment that promotes monocyte/macrophage maturation.
Masri M; Wahl D; Oegema T; Luikart S
Exp Hematol; 1999 Feb; 27(2):345-52. PubMed ID: 10029174
[TBL] [Abstract][Full Text] [Related]
6. A fragment of alpha-actinin promotes monocyte/macrophage maturation in vitro.
Luikart S; Wahl D; Hinkel T; Masri M; Oegema T
Exp Hematol; 1999 Feb; 27(2):337-44. PubMed ID: 10029173
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis of specific inhibition of urokinase plasminogen activator by amiloride.
Jankun J; Skrzypczak-Jankun E
Cancer Biochem Biophys; 1999 Jul; 17(1-2):109-23. PubMed ID: 10738907
[TBL] [Abstract][Full Text] [Related]
8. Non-muscle alpha-actinin-4 interacts with plasminogen activator inhibitor type-1 (PAI-1).
Magdolen U; Schroeck F; Creutzburg S; Schmitt M; Magdolen V
Biol Chem; 2004 Sep; 385(9):801-8. PubMed ID: 15493875
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of plasminogen activation protects against ganglion cell loss in a mouse model of retinal damage.
Zhang X; Chaudhry A; Chintala SK
Mol Vis; 2003 Jun; 9():238-48. PubMed ID: 12813409
[TBL] [Abstract][Full Text] [Related]
10. Effect of urokinase type plasminogen activator on
Roldán-Olarte M; Maillo V; Sánchez-Calabuig MJ; Beltrán-Breña P; Rizos D; Gutiérrez-Adán A
Reproduction; 2017 Sep; 154(3):231-240. PubMed ID: 28667127
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta 1 stimulates macrophage urokinase expression and release of matrix-bound basic fibroblast growth factor.
Falcone DJ; McCaffrey TA; Haimovitz-Friedman A; Garcia M
J Cell Physiol; 1993 Jun; 155(3):595-605. PubMed ID: 7684044
[TBL] [Abstract][Full Text] [Related]
12. Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes.
Stoppelli MP; Corti A; Soffientini A; Cassani G; Blasi F; Assoian RK
Proc Natl Acad Sci U S A; 1985 Aug; 82(15):4939-43. PubMed ID: 2991901
[TBL] [Abstract][Full Text] [Related]
13. Urokinase plasminogen activator is a central regulator of macrophage three-dimensional invasion, matrix degradation, and adhesion.
Fleetwood AJ; Achuthan A; Schultz H; Nansen A; Almholt K; Usher P; Hamilton JA
J Immunol; 2014 Apr; 192(8):3540-7. PubMed ID: 24616477
[TBL] [Abstract][Full Text] [Related]
14. The cowpox virus serpin SPI-3 complexes with and inhibits urokinase-type and tissue-type plasminogen activators and plasmin.
Turner PC; Baquero MT; Yuan S; Thoennes SR; Moyer RW
Virology; 2000 Jul; 272(2):267-80. PubMed ID: 10873770
[TBL] [Abstract][Full Text] [Related]
15. The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes.
Estreicher A; Mühlhauser J; Carpentier JL; Orci L; Vassalli JD
J Cell Biol; 1990 Aug; 111(2):783-92. PubMed ID: 2166055
[TBL] [Abstract][Full Text] [Related]
16. Reduction of mouse atherosclerosis by urokinase inhibition or with a limited-spectrum matrix metalloproteinase inhibitor.
Hu JH; Touch P; Zhang J; Wei H; Liu S; Lund IK; Høyer-Hansen G; Dichek DA
Cardiovasc Res; 2015 Mar; 105(3):372-82. PubMed ID: 25616415
[TBL] [Abstract][Full Text] [Related]
17. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
Kobayashi H
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):623-32. PubMed ID: 8808830
[TBL] [Abstract][Full Text] [Related]
18. Natural and synthetic inhibitors of the tumor-associated serine protease urokinase-type plasminogen activator.
Magdolen V; Arroyo de Prada N; Sperl S; Muehlenweg B; Luther T; Wilhelm OG; Magdolen U; Graeff H; Reuning U; Schmitt M
Adv Exp Med Biol; 2000; 477():331-41. PubMed ID: 10849761
[No Abstract] [Full Text] [Related]
19. Urokinase-type plasminogen activator (uPA) modulates monocyte-to-macrophage differentiation and prevents Ox-LDL-induced macrophage apoptosis.
Paland N; Aharoni S; Fuhrman B
Atherosclerosis; 2013 Nov; 231(1):29-38. PubMed ID: 24125407
[TBL] [Abstract][Full Text] [Related]
20. The THP-1 cell line is a urokinase-secreting mononuclear phagocyte with a novel defect in the production of plasminogen activator inhibitor-2.
Gross TJ; Sitrin RG
J Immunol; 1990 Mar; 144(5):1873-9. PubMed ID: 2307845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
